Combination ACEI and ARB therapy: additional benefit in renoprotection?
MW Taal, BM Brenner - Current opinion in nephrology and …, 2002 - journals.lww.com
MW Taal, BM Brenner
Current opinion in nephrology and hypertension, 2002•journals.lww.comAt present we recommend the addition of angiotensin receptor blocker therapy in patients
with continued hypertension or proteinuria despite angiotensin-converting enzyme
inhibition. Further long-term studies are required to evaluate more fully the renoprotective
potential of this combination.
with continued hypertension or proteinuria despite angiotensin-converting enzyme
inhibition. Further long-term studies are required to evaluate more fully the renoprotective
potential of this combination.
Summary
At present we recommend the addition of angiotensin receptor blocker therapy in patients with continued hypertension or proteinuria despite angiotensin-converting enzyme inhibition. Further long-term studies are required to evaluate more fully the renoprotective potential of this combination.
Lippincott Williams & Wilkins